PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.66
Similar ESG score to VKTX's 57.87. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
53.97
Environmental score 1.1-1.2x VKTX's 49.62. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
56.70
Social score 90-95% of VKTX's 61.44. Bill Ackman would demand clear social improvement catalysts.
56.32
Governance score 90-95% of VKTX's 62.56. Bill Ackman would demand clear governance improvement catalysts.